Beck Bode LLC Sells 230 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Beck Bode LLC decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,180 shares of the financial services provider’s stock after selling 230 shares during the quarter. Beck Bode LLC’s holdings in iShares Biotechnology ETF were worth $1,791,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of IBB. Jacobi Capital Management LLC lifted its stake in iShares Biotechnology ETF by 3.7% in the third quarter. Jacobi Capital Management LLC now owns 2,539 shares of the financial services provider’s stock valued at $310,000 after buying an additional 91 shares in the last quarter. PFG Investments LLC lifted its stake in iShares Biotechnology ETF by 4.8% in the third quarter. PFG Investments LLC now owns 2,013 shares of the financial services provider’s stock valued at $246,000 after buying an additional 93 shares in the last quarter. Huntington National Bank lifted its stake in iShares Biotechnology ETF by 7.4% in the third quarter. Huntington National Bank now owns 1,450 shares of the financial services provider’s stock valued at $177,000 after buying an additional 100 shares in the last quarter. HB Wealth Management LLC lifted its stake in iShares Biotechnology ETF by 5.9% in the fourth quarter. HB Wealth Management LLC now owns 1,892 shares of the financial services provider’s stock valued at $257,000 after buying an additional 105 shares in the last quarter. Finally, Peterson Wealth Management lifted its stake in iShares Biotechnology ETF by 2.9% in the third quarter. Peterson Wealth Management now owns 3,743 shares of the financial services provider’s stock valued at $458,000 after buying an additional 106 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB traded down $1.45 during trading on Tuesday, reaching $126.92. The company had a trading volume of 1,071,553 shares, compared to its average volume of 1,786,840. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16. The business’s fifty day moving average price is $134.12 and its 200 day moving average price is $129.88.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were given a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.40%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.